"Pioneering the Future of Malaria Prevention"
Safe, Effective, and Enduring Solutions
Equity Vaccines Limited, a subsidiary of Equity Health Group, is at the forefront of the fight against malaria. Our mission is to develop innovative, effective, and accessible vaccines that address one of the world’s most pressing public health challenges. Our flagship project, the Equivac Malaria Vaccine, is designed to offer enhanced protection against Plasmodium falciparum, the most dangerous malaria parasite.
“Join us in our journey to eliminate malaria and improve global health.”
Our Vision
At Equity Vaccines Limited, we envision a world where malaria is no longer a threat to millions. Our commitment to scientific excellence, ethical research, and community engagement drives us to develop vaccines that save lives and build healthier futures.
Key Milestones
Commencement of Animal Trials for Equivac Malaria Vaccine”
Data Collection and Analysis Initiated”
Report and Publication of Preclinical Findings”
News & Updates​
Stay informed with the latest developments in our research and vaccine trials. From groundbreaking discoveries to community engagement events, we keep you connected with our progress.
